Contributors: Ryan Wesley Brown and Taylor Hertzler
To learn more about Ryan and Taylor, click here.
Physician-owned distributorships (PODs) have long been treated as a compliance minefield. Federal regulators have long warned that these arrangements - where physicians hold ownership interests in companies that sell medical devices or services they can influence - are inherently suspect under the Anti-Kickback Statute (AKS). Against that backdrop, a recent Advisory Opinion from the U.S. Department of Health & Human Services’ Office of the Inspector General (HHS-OIG) approving a physician investment structure has drawn attention across the healthcare industry. While the Opinion does not necessarily signal a wholesale change in enforcement posture, it does provide a useful concrete roadmap for how narrowly structured physician investment arrangements can survive regulatory scrutiny.
HHS-OIG has been skeptical of such POD arrangements due to a concern that financial incentives can distort clinical judgment. When physicians profit from products or services they order, recommend, or use, regulators worry that decisions may be driven by return on investment rather than medical necessity or cost-effectiveness.
In a 2013 Special Fraud Alert, HHS-OIG stated that such PODs are “inherently suspect under the antikickback statute” given the incentive they create for physicians to make medical decisions based on personal profit instead of medical necessity. For example, since the physicians in the Opinion were investors in the medical device company - and therefore received remuneration in proportion to the company’s profits - they were incentivized to use their medical position to make others purchase the company’s products. The Special Fraud Alert identified four major concerns with PODs: (1) corruption of medical judgment, (2) overutilization, (3) increased costs to federal health care programs and beneficiaries, and (4) unfair competition. HHS-OIG’s concerns are especially strong in the context of medical devices where the physician has a strong say over the brand and type of device chosen for a patient (noting implantable medical devices in particular).
If a physician receives income through such a POD, there are two ways to address AKS risk: (1) demonstrate that no remuneration they receive is made for the purpose of inducing referrals or (2) satisfy all elements of a safe harbor. The former option means the physician is not violating the AKS at all; however, demonstrating the absence of an illegal purpose is difficult, especially since a remuneration is illegal if even one purpose of it is to induce referrals. A safe harbor is an arrangement that otherwise implicates the AKS but that HHS-OIG treats as non-offenses due to their low likelihood of generating illegal remuneration. Safe harbors typically consist of several elements that a party must satisfy to take advantage of the safe harbor’s protection.
In the Opinion, HHS-OIG found that the physicians’ arrangement satisfied the small-entity-investment safe harbor, which provides that for purposes of the AKS, “remuneration” does not include returns on investment, provided the arrangement satisfies the following elements:
- The physicians own no more than 40 percent of the company.
- Physicians are offered the same investment terms as other investors.
- Physicians’ investment terms are not related to the volume of business they generate for the company.
- Passive investors’ investment terms do not require them to generate business for the company.
- The company and its investors market and furnish the company’s items or services on the same terms to passive investors as to non-investors.
- Business generated by physicians is no more than 40 percent of the company’s gross revenue.
- The company cannot loan funds to a physician for the purpose of that physician buying an investment interest.
- Returns on investment must be directly proportional to the amount of an investor’s investment.
Although the Opinion gives few specifics on the POD arrangement, the requestor certified the POD arrangement complies with each of the above. Therefore, HHS-OIG concluded that the arrangement satisfies the small-entity-investment safe harbor as long as that compliance remains in place.
The Opinion stresses that similar arrangements that fail to satisfy even one of the elements could still raise fraud and abuse risks under the AKS, especially arrangements where physicians are ordering, purchasing, or using their devices over other treatments.
From a legal perspective, the Opinion is not revolutionary. HHS-OIG has always treated arrangements meeting all elements of an applicable safe harbor as a non-offense under the AKS. What makes this Opinion notable is that PODs rarely fit cleanly within a safe harbor, and many fail on multiple elements - particularly revenue thresholds, differential investment terms, or informal expectations around utilization.
The Opinion does not suggest that HHS-OIG is reducing its scrutiny of physician investment models. To the contrary, it reiterates that failure to satisfy even one safe harbor element can resurrect significant fraud-and-abuse risk, especially where physicians actively influence purchasing or utilization. Nevertheless, several lessons emerge:
- Safe harbor compliance must be exact, not approximate. The small entity investment safe harbor is unforgiving. Ownership percentages, revenue sourcing, and investment terms must be continuously monitored - not just at deal closing.
- Governance and documentation matter. Equal treatment of physician and non-physician investors must be real and demonstrable. Side letters, informal understandings, or preferential economics can undermine the entire structure.
- Ongoing compliance is as important as initial design. An arrangement that satisfies the safe harbor today may drift out of compliance as revenue sources shift or ownership changes.
- Most PODs will still be high-risk. This Opinion should not be read as an endorsement of physician distributorships generally. It reflects a narrowly tailored fact pattern with unusually disciplined safeguards.
- Early legal and compliance involvement is essential. Retrofitting a non-compliant investment structure is more difficult - and riskier - than designing one correctly from the outset.
The Advisory Opinion offers reassurance that physician investment in healthcare companies is not categorically prohibited under the AKS. However, it also underscores just how narrow the path to compliance can be. These arrangements demand rigorous structuring, ongoing oversight, and a willingness to walk away if the business model cannot operate within strict boundaries. In short, PODs remain legally possible, but only for organizations prepared to treat compliance as a core operational requirement, not a secondary consideration.
Contact Ryan at: [email protected]
Contact Taylor at: [email protected]